UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease

PloS one, 2016-01, Vol.11 (1), p.e0146654-e0146654

2016

Volltextzugriff (PDF)

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats

PloS one, 2015-04, Vol.10 (4), p.e0125603

2015

Volltextzugriff (PDF)

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

The New England journal of medicine, 2010-08, Vol.363 (9), p.820-829

2010

Volltextzugriff (PDF)

Effect of denosumab on trabecular bone score in de novo kidney transplant recipients

Nephrology, dialysis, transplantation, 2019-10, Vol.34 (10), p.1773-1780

2019

Volltextzugriff (PDF)

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study

Nephrology, dialysis, transplantation, 2013-02, Vol.28 (2), p.352-359

2013

Volltextzugriff (PDF)

Chronic Norovirus Infection after Kidney Transplantation: Molecular Evidence for Immune-Driven Viral Evolution

Clinical infectious diseases, 2010-08, Vol.51 (3), p.307-314

2010

Volltextzugriff (PDF)

Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab

Kidney & blood pressure research, 2019-10, Vol.44 (5), p.1285-1293

2019

Volltextzugriff (PDF)

Relationship of Serum Bicarbonate Levels with 1-Year Graft Function in Kidney Transplant Recipients in Switzerland

Kidney & blood pressure research, 2019-10, Vol.44 (5), p.1179-1188

2019

Volltextzugriff (PDF)

Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation

Nephrology, dialysis, transplantation, 2016-11, Vol.31 (11), p.1826-1834

2016

Volltextzugriff (PDF)

The Damaged Spinal Cord Is a Suitable Target for Stem Cell Transplantation

Neurorehabilitation and neural repair, 2020-08, Vol.34 (8), p.758-768

2020

Volltextzugriff (PDF)

Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid–base balance

Nephrology, dialysis, transplantation, 2021-10, Vol.36 (10), p.1806-1820

2021

Volltextzugriff (PDF)

Circular RNA-based biomarkers in blood of patients with Fabry disease and related phenotypes

Journal of medical genetics, 2022-03, Vol.59 (3), p.279

2022

Volltextzugriff (PDF)

Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients

Clinical journal of the American Society of Nephrology, 2013-02, Vol.8 (2), p.280-289

2013

Volltextzugriff (PDF)

Safety of Kidney Biopsy when Performed as an Outpatient Procedure

Kidney & blood pressure research, 2021-06, Vol.46 (3), p.310-322

2021

Volltextzugriff (PDF)

Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study

Kidney & blood pressure research, 2020-10, Vol.45 (5), p.758-767

2020

Volltextzugriff (PDF)

Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab

Transplantation, 2017-09, Vol.101 (9), p.2139

2017

Volltextzugriff (PDF)

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study

PloS one, 2013-01, Vol.8 (1), p.e53016-e53016

2013

Volltextzugriff (PDF)

Chronic Norovirus Infection as a Risk Factor for Secondary Lactose Maldigestion in Renal Transplant Recipients: A Prospective Parallel Cohort Pilot Study

Transplantation, 2017-06, Vol.101 (6), p.1455

2017

Volltextzugriff (PDF)

The Circular RNA ciRs-126 Predicts Survival in Critically Ill Patients With Acute Kidney Injury

Kidney international reports, 2018-09, Vol.3 (5), p.1144-1152

2018

Volltextzugriff (PDF)

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)

Nephrology, dialysis, transplantation, 2006-03, Vol.21 (3), p.598-604

2006

Volltextzugriff (PDF)

Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term

Clinical kidney journal, 2022-06, Vol.15 (6), p.1152-1159

2022

Volltextzugriff (PDF)

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection

Transplantation, 2009-06, Vol.87 (12), p.1837

2009

Volltextzugriff (PDF)

The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1

American journal of physiology. Renal physiology, 2016-06, Vol.310 (11), p.F1284-F1294

2016

Volltextzugriff (PDF)

Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases

Clinical journal of the American Society of Nephrology, 2010-07, Vol.5 (7), p.1312-1329

2010

Volltextzugriff (PDF)

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease

PloS one, 2014-03, Vol.9 (3), p.e92232-e92232

2014

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Englisch
(213)
Japanisch
(31)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

Effect of denosumab on trabecular bone score in de novo kidney transplant recipients

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study

Chronic Norovirus Infection after Kidney Transplantation: Molecular Evidence for Immune-Driven Viral Evolution

Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab

Relationship of Serum Bicarbonate Levels with 1-Year Graft Function in Kidney Transplant Recipients in Switzerland

Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation

The Damaged Spinal Cord Is a Suitable Target for Stem Cell Transplantation

Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid–base balance

Circular RNA-based biomarkers in blood of patients with Fabry disease and related phenotypes

Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients

Safety of Kidney Biopsy when Performed as an Outpatient Procedure

Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study

Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study

Chronic Norovirus Infection as a Risk Factor for Secondary Lactose Maldigestion in Renal Transplant Recipients: A Prospective Parallel Cohort Pilot Study

The Circular RNA ciRs-126 Predicts Survival in Critically Ill Patients With Acute Kidney Injury

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)

Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection

The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1

Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease

Suchergebnisse filtern